Payload Information
General Information of This Payload
| Payload ID | PAY0NKCWV |
|||||
|---|---|---|---|---|---|---|
| Name | TAMTM |
|||||
| Target(s) | Microtubule (MT) | |||||
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
BIO-106 [Phase 1/2]
Identified from the Human Clinical Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Related Clinical Trial | |||||
| NCT Number | NCT05320588 | Phase Status | Phase 1/2 | ||
| Clinical Description |
A phase 1/2 study of BIO-106 as monotherapy or in combination with pembrolizumab in patients with advanced cancers (starbridge-1).
|
||||
References